Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in <i>TP53</i>-Aberrant Triple-Negative Breast Cancer.

Front Oncol · 2022 · PMC8907582 · PMID 35280756

Europe PMC DOI

hedged sentences

0.0730

closest p · 1.5× alpha

0.4700

boldest claim

The sentences

marginally significantP = 0.0730so close (0.05 < p ≤ 0.1)

Among the PDL1 low advanced breast cancers, CSPG4 high level was also a marginally significant risk factor for poor OS ( P = 0.0730) ( Figure 5D ).

also in 26,082 other papers

an obvious trendP = 0.47not close (p > 0.1)

As for CSPG4, there was an obvious trend of increased level in TP53 -aberrant TNBCs compared with TP53 wild-type TNBCs (median: 3.60 vs 3.29, P = 0.47), although the difference was not statistically significant ( Figure 2D ).

also in 1,006 other papers

marginal significanceno p-value reported

The significance level was 0.05, and the marginal significance level was 0.15.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.